Computational Analysis of FDA-Approved Drugs for Potential Repurposing in Alzheimer’s Disease: Targeting MTOR and NGFR Pathways. Sci. Ess. J 2026, 42 (1), 50-70. https://doi.org/10.69523/sej.2026.42.17130.